GlassScriptPhysician profile
Nathan T Glass
NPI 1043623663
$10,668.98
in general payments reported to CMS, 2019-2025
49 companies · $1,647 in 2025
The $1,647 reported for 2025 was more than what 88% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,371 · 2022: $2,508 · 2023: $2,479 · 2024: $2,663 · 2025: $1,647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,789.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,789.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,461.19 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $1,062.33 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,035.02 | 2021-2025 | Farxiga, Airsupra, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $944.38 | 2021-2025 | Jardiance, Stiolto Respimat, Spiriva Respimat |
| Lilly USA, LLC | $906.41 | 2021-2025 | Mounjaro, Jardiance, Emgality |
| Pfizer INC. | $783.39 | 2021-2025 | |
| Abbvie INC. | $767.05 | 2021-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $483.93 | 2021-2024 | |
| Amarin Pharma, INC. | $348.09 | 2021-2023 | |
| Exact Sciences Corporation | $225.63 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Biohaven Pharmaceutical Holding Company LTD. | $200.56 | 2022 | |
| Amgen INC. | $193.26 | 2022-2025 | Tezspire, Repatha, Otezla |
| Averitas Pharma INC. | $172.55 | 2023-2025 | Qutenza |
| Azurity Pharmaceuticals, INC. | $141.07 | 2023-2025 | Edarbi, Azmiro, Edarbi |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $133.63 | 2021-2023 | Xifaxan, Trulance |
Show all 49 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $126.24 | 2023-2024 | Accrufer |
| Biohaven Pharmaceuticals, INC. | $115.44 | 2021 | |
| Janssen Pharmaceuticals, INC | $114.48 | 2024-2025 | Spravato, Xarelto |
| Novartis Pharmaceuticals Corporation | $109.10 | 2021-2024 | |
| Dexcom, INC. | $98.09 | 2024-2025 | Dexcom G6 Transmitter |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $94.97 | 2021-2025 | Caplyta |
| Ironwood Pharmaceuticals, INC | $91.92 | 2021-2023 | Linzess |
| Medtronic, INC. | $87.49 | 2022-2025 | Inceptiv, Minimed 780g |
| Sanofi-Aventis U.S. LLC | $86.55 | 2022-2025 | |
| E.R. Squibb & Sons, L.L.C. | $83.91 | 2023-2024 | Eliquis |
| Merck Sharp & Dohme LLC | $83.10 | 2022-2025 | Gardasil 9, Capvaxive, Vaxelis |
| Idorsia Pharmaceuticals US INC | $66.02 | 2022-2024 | Quviviq |
| Abbott Laboratories | $61.04 | 2023 | Freestyle Libre 3, Proclaim |
| Takeda Pharmaceuticals U.S.A., INC. | $55.78 | 2021-2023 | Trintellix |
| Eisai INC. | $47.93 | 2021-2022 | |
| Redhill Biopharma INC. | $40.66 | 2021 | |
| Collegium Pharmaceutical, INC. | $40.56 | 2021 | |
| Csl Behring | $38.84 | 2025 | Hizentra |
| Cequr Corporation | $36.00 | 2023-2024 | Cequr Simplicity |
| Insulet Corporation | $31.77 | 2023-2024 | Omnipod |
| Otsuka America Pharmaceutical, INC. | $31.53 | 2023-2024 | Rexulti |
| Esperion Therapeutics, INC. | $28.37 | 2024-2025 | Nexletol |
| Hikma Pharmaceuticals USA | $27.59 | 2021 | |
| Sunovion Pharmaceuticals INC. | $27.19 | 2022 | |
| Avanir Pharmaceuticals, INC. | $25.33 | 2021-2022 | |
| Daiichi Sankyo INC. | $25.13 | 2025 | Injectafer |
| Hologic Sales and Service, LLC | $23.75 | 2024 | Aptima, Thinprep 2000 Processor |
| Astellas Pharma US INC | $19.89 | 2022 | |
| Ultragenyx Pharmaceutical INC. | $16.74 | 2022 | |
| Virtus Pharmaceuticals LLC | $16.11 | 2021 | |
| Phathom Pharmaceuticals, INC. | $15.46 | 2025 | Voquezna |
| Pacira Pharmaceuticals Incorporated | $15.26 | 2025 | Zilretta, Iovera |
| Arbor Pharmaceuticals, INC. | $14.48 | 2021 | |
| Almatica Pharma LLC | $13.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nathan Glass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.